Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 11/2014

01-11-2014 | Letter

Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen

Authors: M. Tadrous, M. M. Mamdani, D. N. Juurlink, M. D. Krahn, L. E. Lévesque, S. M. Cadarette

Published in: Osteoporosis International | Issue 11/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Pazianas M, Abrahamsen B (2014) Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis. Osteoporosis Int. DOI 10.​1007/​s00198-014-2788-0
2.
3.
Bafeta A, Trinquart L, Seror R, Ravaud P (2013) Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ 347:f3675PubMedCrossRefPubMedCentral
4.
Druyts E, Thorlund K, Humphreys S, Lion M, Cooper CL, Mills EJ (2013) Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection. Clin Epidemiol 5:173–183PubMedPubMedCentral
5.
Jansen JP, Fleurence R, Devine B et al (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health: J Int Soc Pharmacoeconomics Outcome Res 14(4):417–428CrossRef
6.
Boonen S, Black DM, Colon-Emeric CS et al (2010) Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc 58(2):292–299PubMedCrossRefPubMedCentral
7.
8.
Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109–117PubMedCrossRef
Metadata
Title
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen
Authors
M. Tadrous
M. M. Mamdani
D. N. Juurlink
M. D. Krahn
L. E. Lévesque
S. M. Cadarette
Publication date
01-11-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2789-z

Other articles of this Issue 11/2014

Osteoporosis International 11/2014 Go to the issue

Original Article

Computed digital absorptiometry for measurement of phalangeal bone mineral mass on a slot-scanning digital radiography system

Original Article

Physical activity and 10-year incidence of self-reported vertebral fractures in Japanese women: The Japan Public Health Center-based Prospective Study

Short Communication

Radiation-free spinometry adds to the predictive power of historical height loss in clinical vertebral fracture assessment

Original Article

Patient perceptions of provider barriers to post-fracture secondary prevention

Original Article

Predictors of low bone mineral density of the stroke-affected hip among ambulatory individuals with chronic stroke

Original Article

Reconsideration of the relevance of mild wedge or short vertebral height deformities across a broad age distribution